Session 1.3.3



Nanomedicine, tissue regeneration, theranostic, drug delivery, stem cells, gene delivery.


  • KN : Dan PEER (Tel-Aviv University, IL)

  • IL1: Andreas BERNKOP-SCHNURCH (University of Innsbruck, AT)

  • IL2: Jesus SANTAMARIA, (Aragon Nanosciences Institute, U-Zaragoza, ES)


Nanomedicine, the application of nanotechnology to human healthcare, is at the forefront of modern healthcare and disease prevention. Nanoparticles offer a new platform for drug delivery that can greatly increase the targeting and effectiveness of therapy. The current session aims at presenting advances in nanomedicine in relation to the development of novel engineering and advanced tools to treat diseases and improve human health.